Whitehead Institute Founding Member Rudolf Jaenisch has been honored with the 2025 Ogawa-Yamanaka Stem Cell Prize.
Awarded by Gladstone Institutes, the prize recognizes Jaenisch’s seminal role in establishing and advancing the field of induced pluripotent stem cells (iPSCs)—adult skin or blood cells that can be reprogrammed into an embryonic stem cell–like state.
These reprogrammed cells can mature into nearly any cell type in the body, making them powerful tools for investigating molecular mechanisms of disease, developing cell therapies, and improving drug discovery and testing.
In announcing the award, Gladstone Institutes emphasized that Jaenisch’s “pivotal discoveries” have deepened scientific understanding of gene regulation, cellular reprogramming, and the promise of regenerative medicine. His work in iPSCs, they noted, “has opened the door to the development of therapies for a wide range of genetic and degenerative diseases.”
